Serum Trypsin Inhibitor Activity in Detecting Cancer
Author Information
Author(s): J. H. KEMP, J. M. JOHNSTONE
Primary Institution: Department of Pathology, Grimsby General Hospital
Hypothesis
Can serum trypsin inhibitor activity serve as a reliable screening test for malignant disease?
Conclusion
The study found that while serum trypsin inhibitor activity is low in normal individuals, it is not a reliable screening test for malignant disease.
Supporting Evidence
- The study included 1043 individuals to assess serum trypsin inhibitor activity.
- Normal individuals showed low serum trypsin inhibitor activity.
- High serum trypsin inhibitor activity was noted in certain non-malignant conditions.
- The test was not regularly raised in cases of malignant disease.
Takeaway
This study looked at a blood test to see if it could help find cancer. It found that while the test can show some signs of disease, it's not good enough to use all the time.
Methodology
The study estimated serum trypsin inhibitor activity using a specific substrate, benzoyl-l-arginine amide hydrochloride, in a large sample of individuals.
Limitations
The test fails as a satisfactory screening test for malignant disease due to low specificity and false positives in certain conditions.
Participant Demographics
Participants included hospital inpatients and outpatients, with a mix of normal and various disease conditions.
Want to read the original?
Access the complete publication on the publisher's website